What is VTRS's five-year median P/S?

0.9x. Half of VTRS's weekly readings over the last five years were higher and half were lower. This page has 296 weekly readings, from Mar 1, 2021 to Oct 26, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares VTRS only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Viatris (VTRS) valuation history

Health Care

$19.20

Latest weekly close · Market cap $22.3B

Historically high

Viatris' P/S of 1.5x is the highest of its weekly readings over the last five years (as of Oct 30, 2026).

Forward P/E 6.7× (analyst estimates, not ranked).
No P/E: earnings over the last twelve months are negative.

Weekly P/S with its 5-year range

P/S each weekMiddle half of the last 5 years5-year median 0.9×

5-year median: 0.9×
10-year median: 0.9×
5-year low to high: 0.6× to 1.5×
Versus 5-year median: +77%

P/S

100thpercentile

of its weekly readings over the last five years

Growth, last 12 months vs the year before

Revenue: +4%accelerating
EPS: n/m

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

P/S at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

VTRS P/S at each year-end
Year-end	P/S	5-year percentile
Dec 29, 2025	1.0×	90
Dec 30, 2024	1.0×	81
Dec 25, 2023	n/m	Too little history
Dec 26, 2022	0.8×	61
Dec 27, 2021	1.0×	66

Health Care peers on P/S

Each percentile compares a stock with its own last five years.

Compare VTRS with peers

Health Care peers of VTRS on P/S
Stock	P/S	Versus its own history	5-year percentile
AXSMAxsome Therapeutics Inc	9.6×	Historically low	0
BMYBristol Myers Squibb	2.5×	Within its usual range	50
CORTCorcept Therapeutics Inc	12.3×	Above its usual range	84
ELANElanco Animal Health Inc	2.3×	Above its usual range	72
JAZZJazz Pharmaceuticals PLC	3.1×	Above its usual range	89

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on VTRS

No articles about VTRS yet. How valuation percentiles work

Loading peers and related research…

About this history

What is VTRS's current P/S?: Viatris' P/S of 1.5x is the highest of its weekly readings over the last five years (as of Oct 30, 2026).
What is VTRS's five-year median P/S?: 0.9x. Half of VTRS's weekly readings over the last five years were higher and half were lower. This page has 296 weekly readings, from Mar 1, 2021 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares VTRS only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.